Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2009 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
| Sales | 4 | 36,321 | 802 | 1,152 | 2,020 |
| Gross Profit | 4 | 36,321 | 802 | 1,152 | 2,020 |
| Operating Expenses | 2,496 | 15,477 | 4,357 | 6,136 | 7,194 |
| Operating Income | -2,492 | 20,844 | -3,555 | -4,984 | -5,174 |
| Other Income | 20 | 177 | -14 | 68 | 60 |
| Pre-tax Income | -2,472 | 21,021 | -3,569 | -4,916 | -5,114 |
| Net Income Continuous | -2,472 | 21,021 | -3,569 | -4,916 | -5,114 |
| Net Income | $-2,472 | $21,021 | $-3,569 | $-4,916 | $-5,114 |
| EPS Basic Total Ops | -0.78 | 6.42 | -1.08 | -1.50 | -1.56 |
| EPS Basic Continuous Ops | -0.76 | 6.47 | -1.10 | -1.51 | -1.57 |
| EPS Diluted Total Ops | -0.78 | 6.42 | -1.08 | -1.50 | -1.56 |
| EPS Diluted Continuous Ops | -0.76 | 6.46 | -1.10 | -1.51 | -1.57 |
| EBITDA(a) | $-2,427 | $20,949 | $-3,444 | $-4,881 | $-5,071 |